2025 Vaccination Campaign: Who, Where, Doses
- With the return to classes and a rise in respiratory viruses,the Ministry of Health has advanced the 2025 Vaccination Campaign.
- The Ministry of Health emphasizes that vaccinations are a crucial tool in preventing the spread of respiratory illnesses.
- Furthermore, multiple vaccines can be administered concurrently without affecting their effectiveness.
Chile Advances 2025 Vaccination Campaign Amidst Respiratory Virus Surge
Table of Contents
- Chile Advances 2025 Vaccination Campaign Amidst Respiratory Virus Surge
- Chile’s 2025 Vaccination Campaign: Your Questions Answered
Protecting vulnerable groups against influenza, COVID-19, and RSV.
With the return to classes and a rise in respiratory viruses,the Ministry of Health has advanced the 2025 Vaccination Campaign. This strategy aims to protect at-risk groups against influenza, COVID-19, and respiratory syncytial virus (RSV), reducing complications and hospitalizations.Immunization is free for those in priority groups and available at public and private centers.
The Ministry of Health emphasizes that vaccinations are a crucial tool in preventing the spread of respiratory illnesses. The vaccination campaign is designed to ensure that the most vulnerable populations receive the necessary protection.
Furthermore, multiple vaccines can be administered concurrently without affecting their effectiveness.
A primary concern among the population is whether multiple vaccines can be administered during a single visit. The answer is yes. “Las tres vacunas pueden administrarse en una misma visita sin influir en su efectividad” (The three vaccines can be administered in the same visit without affecting their effectiveness). The only requirement is that thay are applied to different areas of the body to avoid localized adverse reactions. The advice from the Ministerio de Salud is to take advantage of this opportunity and receive all necessary doses based on age and condition, ensuring complete protection before infections increase.
The Ministry of Health is actively promoting the vaccination campaign to ensure widespread protection against respiratory viruses. Taking advantage of the opportunity to receive all necessary doses is highly encouraged.
The cost of vaccination is “completamente gratuito para quienes forman parte de los grupos de riesgo” (completely free for those who are part of the risk groups), whether they are beneficiaries of Fonasa or Isapre. it can also be done at public health centers and private vaccination centers in agreement with the Ministry of Health. However, those who do not belong to these groups will have to pay for the doses in private centers. It is indeed critically important to verify that the establishment has the appropriate certification to guarantee the quality and conservation of the vaccines.
Access to free vaccination is a key component of the Ministry’s strategy to protect vulnerable populations. Ensuring the quality and conservation of vaccines is also a top priority.
Vaccination Against Influenza: Who Should Get Immunized?
Influenza is a highly contagious respiratory disease that can cause serious complications in certain populations. The 2025 vaccine used in Chile will be from the Sinovac, Anflu® laboratory, which protects against strains AH1N1, AH3N2, and type B.
Priority Groups for Influenza Vaccination
- Health personnel.
- People aged 60 and over.
- People with chronic pathologies between 11 and 59 years old.
- Pregnant women at any stage of pregnancy.
- Children from 6 months up to 5th grade.
- Cocoon strategy for relatives of premature infants older than 37 weeks of gestation.
- Cocoon strategy for relatives of immunosuppressed infants under 6 months.
- Teachers and education assistants in preschool and school up to 8th grade.
- Caregivers of older adults and officials of Long-Stay Establishments for Older Adults (ELEAM).
- Workers in poultry, livestock, and pig farms.
COVID-19: Booster for Those Without a Complete Scheme
Even though COVID-19 is no longer a health emergency, it “sigue circulando y afectando a la población” (continues to circulate and affect the population). Therefore, the vaccination campaign includes the possibility of receiving a booster dose for those who do not have their complete scheme.
The ongoing circulation of COVID-19 underscores the importance of staying up-to-date with vaccinations. A COVID-19 booster is available for those who need it.
Respiratory Syncytial Virus: Protection for the Little Ones
Respiratory syncytial virus is the leading cause of hospitalization in infants, especially in premature babies and babies with complex health conditions. This year, “la inmunización está dirigida a:” (immunization is aimed at):
- Newborns from March 1, 2025.
- Infants born from October 1, 2024.
- Premature babies under 32 weeks or weighing less than 1,500 grams at birth.
- Infants with hemodynamically significant unresolved congenital heart disease or cyanotic heart disease secondary to high-complexity heart disease.
- Premature babies from 32 to 34+6 weeks and weighing between 1,500 to 2,500 grams at birth.
- Newborns or infants undergoing extracorporeal circulation (born from September 30, 2023).
- The medication used, Nirsevimab, is a monoclonal antibody that helps prevent the disease in the little ones. Administration is voluntary but highly recommended.
Protecting infants from RSV is a critical focus of the vaccination campaign. The use of Nirsevimab offers a promising preventative measure.
Chile’s 2025 Vaccination Campaign: Your Questions Answered
This comprehensive guide answers your pressing questions about Chile’s 2025 vaccination campaign, focusing on influenza, COVID-19, and Respiratory Syncytial Virus (RSV). Learn about eligibility, vaccine types, and the importance of protecting vulnerable populations.
General Vaccination Campaign Questions
Can I receive multiple vaccines during a single visit?
Yes, you can receive the influenza, COVID-19, and RSV vaccines during the same visit. The Ministry of Health advises that administering all three vaccines simultaneously does not impact their effectiveness. They should be applied to different areas of the body to minimize localized adverse reactions.
How much do the vaccines cost?
Vaccinations are completely free for individuals who are part of the at-risk groups, regardless of whether they are beneficiaries of Fonasa or Isapre. Those not in the priority groups will need to pay for the doses at private centers.
Where can I get vaccinated?
Eligible individuals can receive vaccinations at both public health centers and private vaccination centers that have an agreement with the Ministry of Health. If you are paying for the vaccine, ensure the private vaccination center has the appropriate certification to guarantee the quality and conservation of the vaccines.
What respiratory viruses does this campaign target?
The 2025 vaccination campaign targets three key respiratory viruses:
Influenza (Flu): Protection against seasonal influenza strains.
COVID-19: Booster doses for those who have not completed their initial vaccination scheme.
Respiratory Syncytial Virus (RSV): Protection for infants and vulnerable newborns.
Why is this vaccination campaign crucial?
The surge in respiratory viruses, timed with the return to classes, necessitates this proactive vaccination campaign. It aims to protect at-risk groups, reduce complications, and minimize hospitalizations. The Ministry of Health strongly emphasizes that vaccinations are a crucial tool in preventing the spread of respiratory illnesses.
Influenza Vaccination Questions
Who should get the influenza vaccine? What are the priority groups for influenza vaccination in Chile?
The following are the priority groups for influenza vaccination:
Health personnel
People aged 60 and over
People with chronic pathologies between 11 and 59 years old
Pregnant women at any stage of pregnancy
Children from 6 months up to 5th grade
Cocoon strategy for relatives of premature infants older than 37 weeks of gestation
Cocoon strategy for relatives of immunosuppressed infants under 6 months
Teachers and education assistants in preschool and school up to 8th grade
Caregivers of older adults and officials of Long-Stay Establishments for Older adults (ELEAM)
Workers in poultry, livestock, and pig farms
What type of influenza vaccine is being used in Chile for 2025?
The 2025 influenza vaccine used in Chile is from the Sinovac, Anflu® laboratory. This vaccine protects against influenza strains AH1N1, AH3N2, and type B.
COVID-19 Vaccination Questions
Is a COVID-19 booster available?
Yes, a COVID-19 booster dose is available for those who do not have their complete vaccination scheme.Even though COVID-19 is no longer classified as a health emergency, it continues to circulate and affect the population, making booster doses crucial.
Do I need a COVID-19 booster if I was already vaccinated?
The availability of a COVID-19 booster is specifically for individuals who have not completed their initial vaccination scheme. If you’re unsure about your vaccination status, consult with your healthcare provider.
RSV Vaccination Questions
Who is eligible for RSV immunization?
This year, immunization is aimed at:
Newborns from March 1, 2025.
Infants born from October 1, 2024.
Premature babies under 32 weeks or weighing less than 1,500 grams at birth.
Infants with hemodynamically important unresolved congenital heart disease or cyanotic heart disease secondary to high-complexity heart disease.
Premature babies from 32 to 34+6 weeks and weighing between 1,500 to 2,500 grams at birth.
* Newborns or infants undergoing extracorporeal circulation (born from September 30, 2023).
What medication is used for RSV immunization?
The medication used is Nirsevimab, a monoclonal antibody that helps prevent RSV disease in infants.
Is RSV immunization mandatory?
Management of Nirsevimab is voluntary but highly recommended to protect infants from the leading cause of hospitalization in this age group.
Key Takeaways: 2025 Vaccination Campaign Summary
| Vaccine | Target Group | Cost | Key Information |
|————–|——————————————————————————|———————–|————————————————————————————————————————————|
| Influenza | High-risk groups (elderly, chronically ill, pregnant women, children, etc.) | Free for risk groups | Protects against AH1N1, AH3N2, and type B strains |
| COVID-19 | Individuals without a complete vaccination scheme | Free for risk groups | Booster dose available due to ongoing circulation of the virus |
| RSV | Infants and vulnerable newborns | Free for target group | Uses Nirsevimab (monoclonal antibody); voluntary but highly recommended |
By understanding the details of this vaccination campaign, you can make informed decisions to protect yourself and your loved ones from respiratory illnesses.